Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2003
12/24/2003WO2003091232A3 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
12/24/2003WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
12/24/2003WO2003064384A3 Environment friendly reagents and process for trifluoromethylsulfinylation of organic compounds
12/24/2003WO2003039454A3 Beta-secretase inhibitors and methods of use
12/24/2003WO2002028829A3 Peptide deformylase inhibitors
12/24/2003CN1463263A Method to inhibit ethylene responses in plants
12/24/2003CN1131870C 新的吡咯磺酰胺化合物 The new pyrrole sulfonamide compound
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/24/2003CA2486215A1 Mitotic kinesin inhibitors
12/23/2003US6667376 Control agents for living-type free radical polymerization and methods of polymerizing
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667318 LFA-1 antagonist compounds
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/18/2003WO2003104249A1 Novel linker for nucleotides
12/18/2003WO2003104220A1 Asymetric synthesis of amino-pyrrolidinones
12/18/2003WO2003103772A1 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma
12/18/2003WO2003103604A2 Gamma lactams as prostaglandin agonists and use thereof
12/18/2003WO2003103567A2 Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors
12/18/2003WO2003074500A3 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
12/18/2003WO2002083030A3 Bifunctional energy-reversible acyl-compositions
12/18/2003US20030232986 Inhibitors of caspases
12/18/2003US20030232841 Amides such as 5-(2-(4-methylpiperazin-1-yl)-phenyl)-furan-2-carboxylic acid 4-chlorobenzylamide, used as antidepressants and for prophylaxis of headaches
12/18/2003US20030232836 Secondary amides such as 2-(4-(2- methoxyphenyl)-1-piperazinyl )-N-(3-methylphenyl)acetamide, used for prophylaxis of impotency
12/18/2003US20030232826 Amidino and guanidino peptidyl compounds
12/18/2003US20030232811 Anthranilic acid derivative
12/18/2003US20030232808 Sulfonyl derivatives
12/18/2003US20030232806 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them
12/18/2003US20030232800 Non-symmetric tripyrranes in the synthesis of novel macrocycles
12/18/2003US20030229949 Hair dyes; fast coloration of keratin fibers
12/18/2003CA2483555A1 Gamma lactams as prostaglandin agonists and use thereof
12/17/2003EP1371645A1 Process for the preparation of the 2'-(R)-Glycopyrronium Enantiomers and their use in medicaments
12/17/2003EP1370525A1 Biguanide derivatives
12/17/2003EP1370522A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370514A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
12/17/2003EP1370258A2 Peptide deformylase inhibitors
12/17/2003EP1257534B1 Novel process for preparing 4-substituted-1h-pyrrole-3-carboxylic acid ester
12/17/2003EP1082302B1 A vla-4 inhibitor: omepupa-v
12/17/2003CN1462268A Substituted cinnamic acid guanidides, method for the production thereof, their use as medicament, and medicine containing these compounds
12/17/2003CN1462267A Method for producing ketocarbodylic acid derivatives
12/17/2003CN1131222C Benzamide derivs and their use as APOB-100 secretion inhibitors
12/17/2003CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides
12/17/2003CN1131202C Calcium receptor-active compounds
12/16/2003US6664262 N-methoxymethyl-5,5-diphenylbarbituric acid
12/16/2003CA2248407C Thermally stable aminosulfur trifluorides
12/16/2003CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
12/11/2003WO2003101959A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases
12/11/2003WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003WO2003101956A1 Pharmaceutical combination
12/11/2003WO2003101449A2 Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
12/11/2003WO2003101448A1 The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
12/11/2003WO2003101391A2 Therapeutic methods
12/11/2003WO2003080566A3 Hif hydroxylase inhibitors
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2003040288A3 Isotopically coded affinity markers 3
12/11/2003WO2002100802A3 Fluorous triphase and other multiphase systems
12/11/2003WO2002085925A3 Melanocortin receptor ligands
12/11/2003WO2002083067A3 Prodrugs via acylation with cinnamate
12/11/2003WO2002062778A3 Anti-thrombotic compounds, production and use thereof as medicaments
12/11/2003WO2002060383A3 Cancer therapy
12/11/2003US20030229229 Anticancer agents; kinase inhibitors; antiallergens; autoimmune disease; rheumatic diseases; skin disorders
12/11/2003US20030229228 Plant safening agents; fungicides
12/11/2003US20030229226 Cathepsin cysteine protease inhibitors
12/11/2003US20030229133 Amidine inhibitors of serine proteases
12/11/2003US20030229094 Acetamides and benzamides that are useful in treating sexual dysfunction
12/11/2003US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents
12/11/2003US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
12/11/2003US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
12/11/2003US20030229070 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonist and alpha-1-blocking action
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections
12/11/2003US20030228978 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
12/11/2003CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003CA2486110A1 Pharmaceutical combination
12/10/2003EP1369692A2 Sensor surface
12/10/2003EP1369416A1 Stable crystals of pyrrole compound
12/10/2003EP1369415A1 Substituted pyrrolyl compounds for the treatment of inflammation
12/10/2003EP1369414A1 Enantiomerically pure Arylcycloalkyl hydroxycarboxylic esters, processes for their preparation and their use as modulators of muscarinic receptors
12/10/2003EP1368389A1 Complexed compounds and use thereof for the polymerisation of olefins
12/10/2003EP1368316A1 Oxoammonium salts and the use thereof
12/10/2003EP1368315A1 Method for preparing amlodipine
12/10/2003EP1368311A1 Delta1 -pyrrolines used in pest control
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003CN1461298A Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins
12/10/2003CN1130403C In situ block copolymer formation during polymerization of vinyl axomatic monomer
12/10/2003CN1130365C Alpha-1 adrenergic compounds, drug composition containing same and their use
12/09/2003US6660742 Alkylation therapy; anticancer agent
12/09/2003US6660741 Coupling an O-protected methoxypyrrolidine or derivatives with N-protected amino acid 2,5-dioxo-pyrrolidinyl ester to form intermediate, deportecting with trifluoroacetic acid to form pyrrolidine-1-carbonyl-2-methylamine or derivatives
12/04/2003WO2003099819A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
12/04/2003WO2003099785A1 Process for the preparation of amorphous atorvastatin calcium
12/04/2003WO2003099784A1 Method for preparation of pharmaceutical-grade disulfide of dithiocarbamates
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099769A1 Anilino liver x-receptor modulators
12/04/2003WO2003099274A1 Hepatitis c virus inhibitors
12/04/2003WO2003099266A2 Acetamides and benzamides that are useful in treating sexual dysfunction
12/04/2003WO2003022217A3 Treatment of excessive radiation (e.g. sunburn) exposure
12/04/2003US20030225271 Compounds useful as reversible inhibitors of cysteine proteases
12/04/2003US20030225270 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis
12/04/2003US20030225228 A catalyst for the polymerization of olefins, contains a titanium zirconium or hafnium complex of a dianionic bidentate ligand, (at least one of donor atoms of the ligand is a nitrogen atom substituted by a pyrrolyl group)
12/04/2003US20030225149 Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
12/04/2003US20030225102 Dipeptidyl peptidase inhibitors; heterocyclic amide and semicarbazide derivatives, e.g., (2-Cyano-1-(piperazine-2-yl)-carbonyl pyrrolidine bis-trifluoroacetate